Back to search

University of Thessaly (UTH)

Μεταγραφική έκφραση της ανάστροφης μεταγραφάσης της τελομεράσης και της 2,3-διοξυγονάσης της ινδολεαμίνης στον καρκίνο του πνεύμονα

Abstract

dc:description

OBJECTIVE: The aim of this study was to investigate the transcriptional expression of hTERT and IDO in lung cancer cell lines as well as in patients with lung cancer (both in malignant and autologous adjacent non affected lung tissue samples). Correlations of their relative expression with clinicopathological parameters of the disease and survival were performed. MATERIAL AND METHODS: Nine human lung cancer cell lines and 28 patients (23 males and five females, mean age 63.4 ± 9.7 years) with primary lung cancer were enrolled in the study. hTERT expression was determined by semi-quantitative PCR and IDO expression by qRT-PCR, using a sample of lung hamartoma as reference. RESULTS: hTERT expression was detected in 8 out of the 9 cell lines (68.96 ± 31.33), in 21/24 patients’ tumor samples (71.00 ± 68.50) and in 3/27 autologous non malignant lung tissues (1.00 (1.00-48.10)) that were examined. The relative expression of hTERT was significantly associated with pΤ (p=0.017), pTNM stage (p=0.037) and tumor volume (p=0.001). In contrast, no significant difference was found with disease free survival, or overall survival. IDO expression was detected in 3 out of the 9 cell lines (4.68 ± 11.08), in 21/24 patients’ tumor samples (8.46 ± 15.18) and in 21/25 autologous non malignant lung tissues (3.28 ± 2.51) that were examined. The relative expression of IDO in lung cancer cell lines (4.7±11.1) was significantly lower than that of all patients’ tumor samples (p=0.014) as well as than that of the autologous non affected lung tissues (p=0.021). Only in ADC the relative expression of IDO was higher in tumor samples than in non malignant lung tissues (p=0.046). No statistically significant differences were noted between ADC and SCC regarding either the tumor samples or the autologous non affected samples. No significant correlations between IDO expression and other clinicopathological parameters were found. However, there was a negative relationship between IDO expression and survival (p=0.033). Although co-expression of the two genes was observed in the majority of tumor samples (75%), their expression was not correlated. CONCLUSION: Direct evidence is provided demonstrating that both hTERT and IDO mRNA can be constitutively expressed in lung cancer and co-expressed in the majority of them. The findings suggest that their expression may serve as a valuable prognostic factor for patients with lung cancer and as potential target for cancer immunotherapy.

Degree

thesis:*
Grantor dc:publisher
University of Thessaly (UTH)
Year dc:date
2008

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kerenidi, Theodora
  • Κερενίδη, Θεοδώρα

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/17166

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kerenidi, Theodora; Κερενίδη, Θεοδώρα. Μεταγραφική έκφραση της ανάστροφης μεταγραφάσης της τελομεράσης και της 2,3-διοξυγονάσης της ινδολεαμίνης στον καρκίνο του πνεύμονα. University of Thessaly (UTH), 2008. http://hdl.handle.net/10442/hedi/17166